Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Hahn

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Medizinische Monatsschrift Fur Pharmazeuten|June 29, 2018
[in Process]Martina Hahn
Journal of Xenobiotics|November 22, 2022
Rates of Divergent Pharmacogenes in a Psychiatric Cohort of Inpatients with Depression-Arguments for Preemptive TestingSibylle Christine Roll, Martina Hahn
Pharmacogenomics|July 10, 2023
The role of phenoconversion in the pharmacogenetics of psychiatric medicationMartina Hahn, Sibylle C Roll
Fortschritte Der Neurologie-Psychiatrie|October 30, 2024
[Correction: Pharmacogenetic testing to optimize psychopharmacotherapy: Case study of a patient with severe depression and lack of treatment success due to genetic polymorphisms for CYP2D6 and CYP2C19]Andreas Philipp Eckert, Martina Hahn
Medizinische Monatsschrift Fur Pharmazeuten|June 30, 2018
A patient with acute mania after discontinuation of lithiumMartina Hahn, Sibylle C Roll
Drug Safety - Case Reports|October 18, 2016
Dosing Recommendations of Aripiprazole Depot with Strong Cytochrome P450 3A4 Inhibitors: A Relapse RiskMartina Hahn, Sibylle C Roll
The Lancet. Psychiatry|January 30, 2023
The relevance of long-acting injectables in the treatment of schizophreniaMartina Hahn, Sibylle Christine Roll
Fortschritte Der Neurologie-Psychiatrie|October 15, 2024
[Pharmacogenetic testing to optimize psychopharmacotherapy: Case study of a patient with severe depression and lack of treatment success due to genetic polymorphisms for CYP2D6 and CYP2C19]Andreas Philipp Eckert, Martina Hahn
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug-Drug Interactions: Drug-Gene, Drug-Gene-Gene and Drug-Drug-Gene InteractionsMartina Hahn, Sibylle C Roll
The Pharmacogenomics Journal|April 29, 2026
CYPRI: a clinical decision-making tool to select psychiatric patients for pharmacogenetic testingIvana Tašková, Nicole Šafářová, Martina Hahn
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Medizinische Monatsschrift Fur Pharmazeuten|June 29, 2018
[in Process]Martina Hahn
Journal of Xenobiotics|November 22, 2022
Rates of Divergent Pharmacogenes in a Psychiatric Cohort of Inpatients with Depression-Arguments for Preemptive TestingSibylle Christine Roll, Martina Hahn
Pharmacogenomics|July 10, 2023
The role of phenoconversion in the pharmacogenetics of psychiatric medicationMartina Hahn, Sibylle C Roll
Fortschritte Der Neurologie-Psychiatrie|October 30, 2024
[Correction: Pharmacogenetic testing to optimize psychopharmacotherapy: Case study of a patient with severe depression and lack of treatment success due to genetic polymorphisms for CYP2D6 and CYP2C19]Andreas Philipp Eckert, Martina Hahn
Medizinische Monatsschrift Fur Pharmazeuten|June 30, 2018
A patient with acute mania after discontinuation of lithiumMartina Hahn, Sibylle C Roll
Drug Safety - Case Reports|October 18, 2016
Dosing Recommendations of Aripiprazole Depot with Strong Cytochrome P450 3A4 Inhibitors: A Relapse RiskMartina Hahn, Sibylle C Roll
The Lancet. Psychiatry|January 30, 2023
The relevance of long-acting injectables in the treatment of schizophreniaMartina Hahn, Sibylle Christine Roll
Fortschritte Der Neurologie-Psychiatrie|October 15, 2024
[Pharmacogenetic testing to optimize psychopharmacotherapy: Case study of a patient with severe depression and lack of treatment success due to genetic polymorphisms for CYP2D6 and CYP2C19]Andreas Philipp Eckert, Martina Hahn
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug-Drug Interactions: Drug-Gene, Drug-Gene-Gene and Drug-Drug-Gene InteractionsMartina Hahn, Sibylle C Roll
The Pharmacogenomics Journal|April 29, 2026
CYPRI: a clinical decision-making tool to select psychiatric patients for pharmacogenetic testingIvana Tašková, Nicole Šafářová, Martina Hahn
Pageof 4